Loading…
Nidan Laboratories and Healthcare (NIDAN)₹13.35−0.37%Healthcare Service Provider
At the end of the Jun 2026 quarter, Nidan Laboratories and Healthcare's shareholders were: promoters 57.02%, public 42.98%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 2,358 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Promoters | 62.77% | 57.02% | 57.02% | 57.02% | 57.02% | 57.02% | 57.02% | 57.02% |
| Public | 37.23% | 42.98% | 42.98% | 42.98% | 42.98% | 42.98% | 42.98% | 42.98% |
| Promoter shares pledged | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 2,776 | 2,843 | 2,789 | 2,580 | 2,488 | 2,436 | 2,361 | 2,358 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Nitin Vitthalrao Thorve | Promoter | 50.19% | 0.00 |
| Roshan Nitin Thorve | Promoter | 6.91% | 0.00 |
| Ramegowda Sonnenahalli Omprakash Gowda | Public | 1.13% | +0.02 |
| Devendra Rajnikant Ladhani | Public | 1.07% | 0.00 |
Promoters held 57.02% of Nidan Laboratories and Healthcare at the end of the Jun 2026 quarter, the same as a year earlier.
No. The Jun 2026 filing shows no pledged promoter shares.
Nidan Laboratories and Healthcare had 2,358 shareholders at the end of the Jun 2026 quarter, against 2,580 a year earlier.
Ramegowda Sonnenahalli Omprakash Gowda (Public) held 1.13% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.